FS Arzneimittelindustrie e.V.

Dr. Holger Diener - Geschäftsführer
Daniela von Arnim - Assistentin

Grolmanstr. 44-45
10623 Berlin

d.arnim@fsa-pharma.de
Tel.: 030 88728-1700
Fax: 030 88728-1705

Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.

Physician Payments Sunshine Act (USA)

The example of the United States, where there is even a law requiring transparency (Physician Payments Sunshine Act), demonstrates that a five-year debate was necessary there before it was possible to bring the system "into focus". The initial disclosure is anticipated in September 2014. This underscores how complicated the subject matter is, and demonstrates the ambitious road map and implementation of the transparency initiative in Germany.

The FSA

Information on the „Freiwillige Selbstkontrolle für die Arzneimittelindustrie e. V.“ (FSA) is available at

www.fsa-pharma.de.

Current News

New Press Release: Research-based pharmaceutical companies implement Transparency Code

more

The International Olympic Committee published its indemnity policy for the first time to increase transparency within the organization

more

Allergo Journal "wholeheartedly" supports the transparency initiative of the FSA

more

Survey: Most Physicians Report Being Unaffected By Open Payments Database.

more

Disclosure of payments to health professionals: Going Live

more

Press Contact

wbpr_ Kommunikation
Natalie Schneider
Phone: +49 89/99 59 06-25
Email: natalie.schneider@wbpr.de